MCP
RGNX icon

Militia Capital Partners’s Regenxbio RGNX Stock Holding History

Militia Capital Partners’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$340K Hold
23,600
– – 0.08% 173
2025
Q3 		$228K Hold
23,600
– – 0.06% 190
2025
Q2 		$194K Buy
+23,600
New +$198K 0.04% 175

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Militia Capital Partners's RGNX Position: Q4 2025 in Review

Militia Capital Partners held its Regenxbio (RGNX) position steady in Q4 2025 at 23,600 shares worth $340K. The position accounts for 0.08% of the portfolio, ranked #173.

Militia Capital Partners first reported a position in RGNX in Q2 2025 and has held it in 3 quarters since. 174 funds tracked by Wall St. Rank hold RGNX as of Q4 2025.

  • Militia Capital Partners held 23,600 shares of Regenxbio worth $340K as of Q4 2025.
  • Militia Capital Partners left its Regenxbio share count unchanged in Q4 2025.
  • Regenxbio made up 0.08% of Militia Capital Partners's portfolio in Q4 2025, its #173 holding.
  • Militia Capital Partners first reported a position in Regenxbio in Q2 2025 and has held it in 3 quarters since.
  • 174 funds tracked by Wall St. Rank held Regenxbio as of Q4 2025.

Based on Militia Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.